| Association of fat body mass with vertebral fractures in postmenopausal women with early breast cancer undergoing adjuvant aromatase inhibitor therapy R Pedersini, V Amoroso, F Maffezzoni, F Gallo, A Turla, S Monteverdi, ... JAMA Network Open 2 (9), e1911080-e1911080, 2019 | 28 | 2019 |
| The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy S Monteverdi, R Pedersini, F Gallo, F Maffezzoni, A Dalla Volta, ... Journal of Bone and Mineral Research Plus 5 (2), e10440, 2021 | 17 | 2021 |
| Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy R Pedersini, P di Mauro, S Bosio, B Zanini, A Zanini, V Amoroso, A Turla, ... Scientific Reports 11 (1), 12975, 2021 | 15 | 2021 |
| Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? V Cremaschi, A Abate, D Cosentini, S Grisanti, E Rossini, M Laganà, ... Expert Opinion on Pharmacotherapy 23 (12), 1413-1424, 2022 | 12 | 2022 |
| Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases A Alberti, D Smussi, M Zamparini, A Turla, L Laini, C Marchiselli, ... Frontiers in oncology 12, 997009, 2022 | 10 | 2022 |
| Ovarian strumal carcinoid: Case Report, systematic literature review and pooled analysis A Turla, M Zamparini, M Milione, S Grisanti, V Amoroso, R Pedersini, ... Frontiers in Endocrinology 13, 871210, 2022 | 9 | 2022 |
| Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen A Turla, M Laganà, S Grisanti, A Abate, VD Ferrari, V Cremaschi, S Sigala, ... Endocrine 77 (3), 438-443, 2022 | 8 | 2022 |
| Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data R Pedersini, P di Mauro, V Amoroso, MC Parati, A Turla, M Ghilardi, ... Journal of Geriatric Oncology 11 (6), 976-981, 2020 | 8 | 2020 |
| Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma M Laganà, S Grisanti, R Ambrosini, D Cosentini, A Abate, M Zamparini, ... ESMO open 7 (2), 100422, 2022 | 7 | 2022 |
| Efficacy of the DigniCap System in preventing chemotherapy‐induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device R Pedersini, C Fornaro, P di Mauro, S Bianchi, L Vassalli, V Amoroso, ... International Journal of Nursing Practice 27 (3), e12888, 2021 | 6 | 2021 |
| Case report: exceptional response to second line temozolomide therapy in a patient with metastatic adrenocortical carcinoma D Cosentini, A Turla, O Carminati, S Grisanti, VD Ferrari, M Laganà, ... Frontiers in Endocrinology 12, 674039, 2021 | 6 | 2021 |
| Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: A prospective single-center clinical study R Pedersini, M Zamparini, S Bosio, P di Mauro, A Turla, S Monteverdi, ... Supportive Care in Cancer 30 (8), 6955-6961, 2022 | 5 | 2022 |
| Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? S Grisanti, D Cosentini, M Laganà, A Turla, A Berruti Endocrine 74, 475-477, 2021 | 5 | 2021 |
| Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable … A Turla, M Laganà, A Abate, V Cremaschi, M Zamparini, M Chittò, ... Cancers 15 (18), 4491, 2023 | 3 | 2023 |
| Letter to the Editor From Cosentini et al:“Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival” D Cosentini, M Laganà, A Turla, GAM Tiberio, S Grisanti, A Berruti The Journal of Clinical Endocrinology & Metabolism 107 (7), e3092-e3093, 2022 | 2 | 2022 |
| Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests M Saponaro, L Annunziata, A Turla, I Viganò, M De Laurentiis, M Giuliano, ... International Journal of Molecular Sciences 23 (21), 13604, 2022 | 1 | 2022 |
| Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients R Pedersini, P di Mauro, M Zamparini, S Bosio, B Zanini, V Amoroso, ... in vivo 36 (4), 1860-1867, 2022 | 1 | 2022 |
| Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic C Gurizzan, R Pedersini, C Fornaro, C Sardini, M Zamparini, ... Frontiers in Oncology 11, 707346, 2021 | 1 | 2021 |
| 37P Estrogen-mimetic effects of mitotane in patients with adrenocortical carcinoma: Focus on this neglected toxicity A Turla, M Laganà, V Cremaschi, B Trevisan, A Abate, M Tamburello, ... ESMO Open 9, 2024 | | 2024 |
| Oncological treatment administration at end of life: a retrospective study C Gurizzan, A Esposito, L Lorini, D Smussi, A Turla, A Baggi, M Laganà, ... Future Oncology, 2024 | | 2024 |
